Literature DB >> 9583603

Maximum impact of HIV prevention measures targeted at injecting drug users.

E J van Ameijden1, R A Coutinho.   

Abstract

OBJECTIVE: To examine whether the decrease in HIV incidence and injecting risk behaviours is ongoing in Amsterdam, and to study the determinants of injecting risk behaviours.
DESIGN: Prospective open cohort study (1986-1997) amongst injecting drug users (IDU).
METHODS: HIV incidence was studied using Poisson regression analysis. Trends in injecting risk behaviours were determined using 6645 visits of 879 participants, stratified by HIV serostatus and number of the follow-up visit. Generalized estimating equations were used to account for repeated measurements, and additive model structures were used.
RESULTS: A large initial risk reduction (1986-1991) occurred concerning borrowing and lending of used needles, multiple needle use and frequent injecting. However, except for frequent injecting, the rate of behaviour change significantly decreased, and from 1991-1993 onwards there was no substantial further risk reduction. HIV incidence followed a similar pattern. Injecting risk was much lower at follow-up visits. The following determinants of borrowing and lending among both HIV-positive and negative IDU were largely comparable: young age, non-injecting heroin and cocaine use, frequent tranquillizer use, multiple needle use, injecting with others, and irregular use of needle-exchange programmes.
CONCLUSIONS: The observed residual risk, given the extensive HIV prevention measures in Amsterdam, indicates that further prevention is difficult. Because this risk was associated with an HIV incidence of 3-4% per year, HIV prevalence is likely to be high for many years. Therefore, prevention measures should be maintained because of the possibility of behavioural relapse associated with recent availability of potent HIV treatments. To prevent an HIV epidemic amongst a new generation of drug users, prevention of injecting itself is warranted.

Entities:  

Mesh:

Year:  1998        PMID: 9583603     DOI: 10.1097/00002030-199806000-00012

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  12 in total

1.  Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions.

Authors:  E J van Ameijden; R A Coutinho
Journal:  J Epidemiol Community Health       Date:  2001-05       Impact factor: 3.710

2.  HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic.

Authors:  D C Des Jarlais; M Marmor; P Friedmann; S Titus; E Aviles; S Deren; L Torian; D Glebatis; C Murrill; E Monterroso; S R Friedman
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

3.  Syringe Sharing Among a Prospective Cohort of Street-Involved Youth: Implications for Needle Distribution Programs.

Authors:  Nikki Bozinoff; Evan Wood; Huiru Dong; Lindsey Richardson; Thomas Kerr; Kora DeBeck
Journal:  AIDS Behav       Date:  2017-09

4.  The relationship of sexual dyad and personal network characteristics and individual attributes to unprotected sex among young injecting drug users.

Authors:  V Anna Gyarmathy; Alan Neaigus
Journal:  AIDS Behav       Date:  2007-08-10

5.  Social-structural contexts of needle and syringe sharing behaviours of HIV-positive injecting drug users in Manipur, India: a mixed methods investigation.

Authors:  Venkatesan Chakrapani; Peter A Newman; Murali Shunmugam; Robert Dubrow
Journal:  Harm Reduct J       Date:  2011-05-13

6.  Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal study.

Authors:  Julie Bruneau; Mark Daniel; Michal Abrahamowicz; Geng Zang; François Lamothe; Jean Vincelette
Journal:  Am J Epidemiol       Date:  2011-03-01       Impact factor: 4.897

7.  Reduction in Needle Sharing Among Seattle-Area Injection Drug Users Across 4 Surveys, 1994-2013.

Authors:  Richard D Burt; Hanne Thiede
Journal:  Am J Public Health       Date:  2015-12-21       Impact factor: 9.308

Review 8.  Syringe availability as HIV prevention: a review of modalities.

Authors:  P Coffin
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

9.  Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges.

Authors:  Cari L Miller; Mark Tyndall; Patricia Spittal; Kathy Li; Anita Palepu; Martin T Schechter
Journal:  J Urban Health       Date:  2002-06       Impact factor: 3.671

10.  The role of sexual transmission of HIV infection among injection and non-injection drug users.

Authors:  Steffanie A Strathdee; Susan G Sherman
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.